Treating Clostridioides difficile: Could Microbiota-based Live Biotherapeutic Products Provide the Answer?
Sign Up to like & getrecommendations! Published in 2023 at "Infection and Drug Resistance"
DOI: 10.2147/idr.s400570
Abstract: Abstract Clostridioides difficile infection (CDI) is a pressing health care issue due to the limited effectiveness of current treatments and high recurrence rates. Current available antibiotic options for CDI disrupt the fecal microbiome which predisposes… read more here.
Keywords: live biotherapeutic; clostridioides difficile; microbiota based; based live ... See more keywords
Recent Developments in Mycobacteria-Based Live Attenuated Vaccine Candidates for Tuberculosis
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10112749
Abstract: Vaccination is an excellent approach to stimulating the host immune response and reducing human morbidity and mortality against microbial infections, such as tuberculosis (TB). Bacillus Calmette–Guerin (BCG) is the most widely administered vaccine in the… read more here.
Keywords: mycobacteria based; vaccine candidates; attenuated vaccine; based live ... See more keywords